BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

M. Del Campo Milan, C.R. Oliveira, W. Scheper, R. Zwart, C. Korth, A. Muller-Schiffmann, G Kostallas, H Biverstal, J Presto, J. Johansson, J.J. Hoozemans, C.F. Pereira, C.E. Teunissen

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Alzheimer's disease (AD) is pathologically characterized by the presence of misfolded proteins such as amyloid beta (Aβ) in senile plaques, and hyperphosphorylated tau and truncated tau in neurofibrillary tangles (NFT). The BRI2 protein inhibits Aβ aggregation via its BRICHOS domain and regulates critical proteins involved in initiating the amyloid cascade, which has been hypothesized to be central in AD pathogenesis. We recently detected the deposition of BRI2 ectodomain associated with Aβ plaques and concomitant changes in its processing enzymes in early stages of AD. Here, we aimed to investigate the effects of recombinant BRI2 ectodomain (rBRI2
Original languageEnglish
Pages (from-to)1599-1611
JournalCellular and Molecular Life Sciences
Volume72
Issue number8
DOIs
Publication statusPublished - 2015

Fingerprint Dive into the research topics of 'BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.'. Together they form a unique fingerprint.

Cite this